

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 5.31167012 |
| 2 | muscle filament sliding (GO:0030049) | 5.31167012 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 5.14101187 |
| 4 | sarcomere organization (GO:0045214) | 5.04500124 |
| 5 | actin-mediated cell contraction (GO:0070252) | 4.50443037 |
| 6 | nuclear pore complex assembly (GO:0051292) | 4.43291794 |
| 7 | cardiac myofibril assembly (GO:0055003) | 4.42946831 |
| 8 | myofibril assembly (GO:0030239) | 4.36606910 |
| 9 | nuclear pore organization (GO:0006999) | 4.27066472 |
| 10 | skin morphogenesis (GO:0043589) | 3.97065473 |
| 11 | heart contraction (GO:0060047) | 3.88390647 |
| 12 | heart process (GO:0003015) | 3.88390647 |
| 13 | response to peptidoglycan (GO:0032494) | 3.86929744 |
| 14 | peptidyl-proline hydroxylation (GO:0019511) | 3.80881600 |
| 15 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.80736355 |
| 16 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.76068437 |
| 17 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.75886526 |
| 18 | IMP biosynthetic process (GO:0006188) | 3.69837833 |
| 19 | regulation of cholesterol storage (GO:0010885) | 3.68213893 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 3.65614638 |
| 21 | cardiac muscle cell development (GO:0055013) | 3.63908605 |
| 22 | cardiac cell development (GO:0055006) | 3.61020186 |
| 23 | pore complex assembly (GO:0046931) | 3.59429266 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.55491767 |
| 25 | keratinization (GO:0031424) | 3.55177699 |
| 26 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.52024101 |
| 27 | regulation of gene silencing by miRNA (GO:0060964) | 3.52024101 |
| 28 | regulation of gene silencing by RNA (GO:0060966) | 3.52024101 |
| 29 | glycosphingolipid catabolic process (GO:0046479) | 3.49074812 |
| 30 | IMP metabolic process (GO:0046040) | 3.41454070 |
| 31 | actin filament-based movement (GO:0030048) | 3.39132608 |
| 32 | muscle tissue morphogenesis (GO:0060415) | 3.39074407 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.38364217 |
| 34 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.35077770 |
| 35 | pinocytosis (GO:0006907) | 3.30585564 |
| 36 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.29329123 |
| 37 | protein hydroxylation (GO:0018126) | 3.27524167 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 3.26159577 |
| 39 | 4-hydroxyproline metabolic process (GO:0019471) | 3.26085848 |
| 40 | paraxial mesoderm development (GO:0048339) | 3.25707849 |
| 41 | actomyosin structure organization (GO:0031032) | 3.23869481 |
| 42 | protein localization to endosome (GO:0036010) | 3.21589891 |
| 43 | detection of other organism (GO:0098543) | 3.20267983 |
| 44 | cardiac muscle contraction (GO:0060048) | 3.15891239 |
| 45 | T-helper 1 type immune response (GO:0042088) | 3.15789347 |
| 46 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.12802276 |
| 47 | surfactant homeostasis (GO:0043129) | 3.09416240 |
| 48 | detection of bacterium (GO:0016045) | 3.08331839 |
| 49 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.07831307 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.05828788 |
| 51 | osteoclast differentiation (GO:0030316) | 3.04025826 |
| 52 | glycolipid catabolic process (GO:0019377) | 3.03795486 |
| 53 | response to laminar fluid shear stress (GO:0034616) | 3.02173467 |
| 54 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.98292117 |
| 55 | linoleic acid metabolic process (GO:0043651) | 2.97333778 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95249084 |
| 57 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94526551 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.94521072 |
| 59 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.92592509 |
| 60 | regulation of podosome assembly (GO:0071801) | 2.91112139 |
| 61 | histone H3-K9 demethylation (GO:0033169) | 2.87793166 |
| 62 | cardiac muscle hypertrophy (GO:0003300) | 2.87197914 |
| 63 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.86710707 |
| 64 | regulation of relaxation of muscle (GO:1901077) | 2.84707454 |
| 65 | * glycolytic process (GO:0006096) | 2.84333336 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83908884 |
| 67 | decidualization (GO:0046697) | 2.83289059 |
| 68 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.83071819 |
| 69 | fructose metabolic process (GO:0006000) | 2.82203834 |
| 70 | regulation of cardioblast differentiation (GO:0051890) | 2.80777831 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 2.79295726 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79295726 |
| 73 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79295726 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79295726 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 2.79295726 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79295726 |
| 77 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.78520057 |
| 78 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.77445073 |
| 79 | striated muscle contraction (GO:0006941) | 2.77159147 |
| 80 | barbed-end actin filament capping (GO:0051016) | 2.76542790 |
| 81 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.74644816 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.74618227 |
| 83 | mitotic nuclear envelope disassembly (GO:0007077) | 2.74168125 |
| 84 | striated muscle hypertrophy (GO:0014897) | 2.73804034 |
| 85 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.72615021 |
| 86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.72214694 |
| 87 | apoptotic cell clearance (GO:0043277) | 2.71115631 |
| 88 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.69712108 |
| 89 | detection of external biotic stimulus (GO:0098581) | 2.69698109 |
| 90 | adult heart development (GO:0007512) | 2.68841004 |
| 91 | plasma membrane repair (GO:0001778) | 2.67125574 |
| 92 | oxidative phosphorylation (GO:0006119) | 2.66159083 |
| 93 | muscle hypertrophy (GO:0014896) | 2.65469169 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.65175383 |
| 95 | regulation of fever generation (GO:0031620) | 2.63545669 |
| 96 | nodal signaling pathway (GO:0038092) | 2.63087848 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 2.62442674 |
| 98 | ventricular cardiac muscle cell development (GO:0055015) | 2.62010802 |
| 99 | positive regulation of cholesterol efflux (GO:0010875) | 2.61297505 |
| 100 | response to lipoprotein particle (GO:0055094) | 2.59809550 |
| 101 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.58875025 |
| 102 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.57625941 |
| 103 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.57395190 |
| 104 | nuclear envelope disassembly (GO:0051081) | 2.57112923 |
| 105 | membrane disassembly (GO:0030397) | 2.57112923 |
| 106 | macrophage activation involved in immune response (GO:0002281) | 2.56335409 |
| 107 | Golgi transport vesicle coating (GO:0048200) | 2.55336719 |
| 108 | COPI coating of Golgi vesicle (GO:0048205) | 2.55336719 |
| 109 | cellular response to zinc ion (GO:0071294) | 2.55217954 |
| 110 | cellular response to arsenic-containing substance (GO:0071243) | 2.54560676 |
| 111 | ceramide catabolic process (GO:0046514) | 2.52425578 |
| 112 | germinal center formation (GO:0002467) | 2.51385291 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49802369 |
| 114 | regulation of actin filament-based movement (GO:1903115) | 2.48933965 |
| 115 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.48361614 |
| 116 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48104662 |
| 117 | peptide catabolic process (GO:0043171) | 2.46672201 |
| 118 | detection of biotic stimulus (GO:0009595) | 2.44937123 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.44857685 |
| 120 | protein-lipid complex assembly (GO:0065005) | 2.44082709 |
| 121 | keratinocyte differentiation (GO:0030216) | 2.43442504 |
| 122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42582549 |
| 123 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.42502156 |
| 124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42136973 |
| 125 | * glucose 6-phosphate metabolic process (GO:0051156) | 2.41910766 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.41891431 |
| 127 | positive regulation of extracellular matrix organization (GO:1903055) | 2.40821000 |
| 128 | negative regulation by host of viral transcription (GO:0043922) | 2.40687124 |
| 129 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.39174466 |
| 130 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.38850365 |
| 131 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.38079527 |
| 132 | skeletal muscle adaptation (GO:0043501) | 2.36877057 |
| 133 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36804132 |
| 134 | macrophage differentiation (GO:0030225) | 2.35189494 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.34323275 |
| 136 | regulation of water loss via skin (GO:0033561) | 2.33362761 |
| 137 | wound healing, spreading of epidermal cells (GO:0035313) | 2.33165765 |
| 138 | daunorubicin metabolic process (GO:0044597) | 2.32150213 |
| 139 | polyketide metabolic process (GO:0030638) | 2.32150213 |
| 140 | doxorubicin metabolic process (GO:0044598) | 2.32150213 |
| 141 | RNA stabilization (GO:0043489) | 2.30332133 |
| 142 | mRNA stabilization (GO:0048255) | 2.30332133 |
| 143 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29777462 |
| 144 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.29719823 |
| 145 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.28882376 |
| 146 | fibroblast migration (GO:0010761) | 2.28681044 |
| 147 | ER-nucleus signaling pathway (GO:0006984) | 2.27790934 |
| 148 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.25930100 |
| 149 | cell adhesion mediated by integrin (GO:0033627) | 2.25646617 |
| 150 | endothelial cell chemotaxis (GO:0035767) | 2.25628405 |
| 151 | hypotonic response (GO:0006971) | 2.25485674 |
| 152 | skeletal muscle tissue regeneration (GO:0043403) | 2.25368012 |
| 153 | protein K6-linked ubiquitination (GO:0085020) | 2.25188439 |
| 154 | regulation of integrin activation (GO:0033623) | 2.24882085 |
| 155 | hyaluronan metabolic process (GO:0030212) | 2.23699593 |
| 156 | sexual reproduction (GO:0019953) | 2.23667044 |
| 157 | metaphase plate congression (GO:0051310) | 2.23126112 |
| 158 | positive regulation of heat generation (GO:0031652) | 2.22500332 |
| 159 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.21981148 |
| 160 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.21861329 |
| 161 | mitotic metaphase plate congression (GO:0007080) | 2.21747913 |
| 162 | histone lysine demethylation (GO:0070076) | 2.21521041 |
| 163 | tricarboxylic acid cycle (GO:0006099) | 2.20561727 |
| 164 | nucleobase biosynthetic process (GO:0046112) | 2.20502283 |
| 165 | ribosomal small subunit assembly (GO:0000028) | 2.20071405 |
| 166 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.19772879 |
| 167 | notochord development (GO:0030903) | 2.17796468 |
| 168 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.15621468 |
| 169 | skeletal muscle contraction (GO:0003009) | 2.15131798 |
| 170 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.13200326 |
| 171 | embryonic process involved in female pregnancy (GO:0060136) | 2.13127194 |
| 172 | regulation of mitotic spindle organization (GO:0060236) | 2.12977223 |
| 173 | formation of translation preinitiation complex (GO:0001731) | 2.12893393 |
| 174 | striated muscle atrophy (GO:0014891) | 2.12713003 |
| 175 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.11437332 |
| 176 | positive regulation of lipid storage (GO:0010884) | 2.08913753 |
| 177 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.06918543 |
| 178 | epithelial cell-cell adhesion (GO:0090136) | 2.05801804 |
| 179 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.05572231 |
| 180 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.05269779 |
| 181 | cellular response to interleukin-6 (GO:0071354) | 2.04975541 |
| 182 | DNA replication initiation (GO:0006270) | 2.04088866 |
| 183 | positive regulation of p38MAPK cascade (GO:1900745) | 2.01225939 |
| 184 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.00795492 |
| 185 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.00334724 |
| 186 | nuclear envelope organization (GO:0006998) | 2.00141296 |
| 187 | RNA-dependent DNA replication (GO:0006278) | 2.00113152 |
| 188 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 1.98405568 |
| 189 | mitotic G2 DNA damage checkpoint (GO:0007095) | 1.97636408 |
| 190 | establishment of chromosome localization (GO:0051303) | 1.97521584 |
| 191 | regulation of sequestering of triglyceride (GO:0010889) | 1.97336506 |
| 192 | cardiac right ventricle morphogenesis (GO:0003215) | 1.97241643 |
| 193 | striated muscle cell development (GO:0055002) | 1.96267196 |
| 194 | muscle adaptation (GO:0043500) | 1.95910495 |
| 195 | telomere maintenance via semi-conservative replication (GO:0032201) | 1.95545361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.18071647 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00661661 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26650382 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.18849527 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.83707211 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.64095223 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.34708854 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.23759377 |
| 9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.23759377 |
| 10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.23759377 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20880979 |
| 12 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.18277766 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15262804 |
| 14 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11250855 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06734385 |
| 16 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.06575340 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.05911594 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04780358 |
| 19 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.04283285 |
| 20 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.94111555 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93372914 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93114158 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92812265 |
| 24 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.92377910 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90236249 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89996335 |
| 27 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.87769056 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82566913 |
| 29 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78913514 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78742252 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77445563 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71708648 |
| 33 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71234491 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71054918 |
| 35 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69584258 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67635930 |
| 37 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66846734 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66113593 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.63921983 |
| 40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63056494 |
| 41 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.58438774 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57717192 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57576580 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57140466 |
| 45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53469696 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52646776 |
| 47 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52385582 |
| 48 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49702839 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49471839 |
| 50 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47478293 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47116624 |
| 52 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.45843791 |
| 53 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43690926 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43379496 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42848364 |
| 56 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42843153 |
| 57 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.42590684 |
| 58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41846620 |
| 59 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.39888040 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38607237 |
| 61 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37774096 |
| 62 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.36852166 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35761857 |
| 64 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35465358 |
| 65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34874551 |
| 66 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.34032720 |
| 67 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.31790294 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31508398 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31453135 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29423809 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29292341 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29233419 |
| 73 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28888864 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28160211 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27572533 |
| 76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27296023 |
| 77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27296023 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27084114 |
| 79 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26835176 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26601510 |
| 81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26308773 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25861810 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25574423 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25086394 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24296506 |
| 86 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.22910227 |
| 87 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21898827 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20103359 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20018261 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19737933 |
| 91 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19085259 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18169781 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18013544 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17990113 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17732657 |
| 96 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17446544 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16930975 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16792438 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16370136 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16247731 |
| 101 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16111537 |
| 102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14736810 |
| 103 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.14580589 |
| 104 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13688577 |
| 105 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.13464586 |
| 106 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13383032 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11400977 |
| 108 | MYC_22102868_ChIP-Seq_BL_Human | 1.10530007 |
| 109 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10090633 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09752585 |
| 111 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09040033 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08986507 |
| 113 | MAF_26560356_Chip-Seq_TH1_Human | 1.08782249 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08401861 |
| 115 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08248318 |
| 116 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.07576717 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07321987 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07222746 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06761113 |
| 120 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06513160 |
| 121 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06273221 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06191623 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06069530 |
| 124 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.05687254 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05676371 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05536825 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05024756 |
| 128 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04296804 |
| 129 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03712147 |
| 130 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03404216 |
| 131 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03332537 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03163945 |
| 133 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03143774 |
| 134 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.02823970 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02577160 |
| 136 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02222454 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01855386 |
| 138 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01807579 |
| 139 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01254552 |
| 140 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01254552 |
| 141 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99166635 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99100358 |
| 143 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98911599 |
| 144 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98362528 |
| 145 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.96530612 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96308273 |
| 147 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95907449 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95504219 |
| 149 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95089949 |
| 150 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93969299 |
| 151 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93363188 |
| 152 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.93306116 |
| 153 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.92855299 |
| 154 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92702686 |
| 155 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90264165 |
| 156 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90178619 |
| 157 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89721280 |
| 158 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89366168 |
| 159 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88946276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 3.67129890 |
| 2 | MP0003303_peritoneal_inflammation | 3.55296845 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.41128624 |
| 4 | MP0005451_abnormal_body_composition | 3.23986682 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.17066658 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.95581261 |
| 7 | MP0002796_impaired_skin_barrier | 2.90927036 |
| 8 | MP0000749_muscle_degeneration | 2.83536838 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.57167357 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.44272077 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.18543090 |
| 12 | MP0009840_abnormal_foam_cell | 2.18380025 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.16903424 |
| 14 | MP0005330_cardiomyopathy | 2.15311057 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.14984152 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.12511925 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.08745523 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.07831503 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.05325700 |
| 20 | MP0003828_pulmonary_edema | 2.02627502 |
| 21 | MP0003950_abnormal_plasma_membrane | 2.00397687 |
| 22 | MP0008775_abnormal_heart_ventricle | 1.98983609 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.97892853 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.97576926 |
| 25 | MP0000751_myopathy | 1.94943395 |
| 26 | MP0004947_skin_inflammation | 1.93711195 |
| 27 | MP0000750_abnormal_muscle_regeneration | 1.92715423 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.92581162 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 1.92064133 |
| 30 | MP0000604_amyloidosis | 1.84014501 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.82585987 |
| 32 | MP0008260_abnormal_autophagy | 1.82428747 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.82187366 |
| 34 | MP0003941_abnormal_skin_development | 1.78576517 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.74560613 |
| 36 | MP0003329_amyloid_beta_deposits | 1.73933916 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.72090909 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.72090909 |
| 39 | MP0006082_CNS_inflammation | 1.69802466 |
| 40 | MP0002106_abnormal_muscle_physiology | 1.65386723 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.62384365 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.59323450 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.59194541 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.57847416 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.57068965 |
| 46 | MP0000343_altered_response_to | 1.55393657 |
| 47 | MP0005501_abnormal_skin_physiology | 1.54486806 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53408822 |
| 49 | MP0004510_myositis | 1.51738860 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.51561138 |
| 51 | MP0005670_abnormal_white_adipose | 1.50784233 |
| 52 | MP0002269_muscular_atrophy | 1.50240312 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.49154956 |
| 54 | MP0003091_abnormal_cell_migration | 1.47496154 |
| 55 | MP0005023_abnormal_wound_healing | 1.46531360 |
| 56 | MP0003724_increased_susceptibility_to | 1.46426611 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.46121844 |
| 58 | MP0003077_abnormal_cell_cycle | 1.43681672 |
| 59 | MP0001216_abnormal_epidermal_layer | 1.39508788 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.39006758 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.38493640 |
| 62 | MP0006138_congestive_heart_failure | 1.35740768 |
| 63 | MP0003111_abnormal_nucleus_morphology | 1.33083969 |
| 64 | MP0008057_abnormal_DNA_replication | 1.32497158 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.31026141 |
| 66 | MP0010030_abnormal_orbit_morphology | 1.30746750 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.28245684 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.28162913 |
| 69 | MP0000579_abnormal_nail_morphology | 1.25844249 |
| 70 | MP0005369_muscle_phenotype | 1.25025040 |
| 71 | MP0010307_abnormal_tumor_latency | 1.24421688 |
| 72 | MP0005409_darkened_coat_color | 1.24115129 |
| 73 | MP0004484_altered_response_of | 1.22251344 |
| 74 | MP0002127_abnormal_cardiovascular_syste | 1.22225409 |
| 75 | MP0005025_abnormal_response_to | 1.21777251 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.20339094 |
| 77 | MP0004858_abnormal_nervous_system | 1.19993221 |
| 78 | * MP0002088_abnormal_embryonic_growth/wei | 1.17563876 |
| 79 | MP0010678_abnormal_skin_adnexa | 1.17412914 |
| 80 | * MP0003984_embryonic_growth_retardation | 1.17363909 |
| 81 | MP0005275_abnormal_skin_tensile | 1.16600202 |
| 82 | MP0000733_abnormal_muscle_development | 1.16566682 |
| 83 | MP0005666_abnormal_adipose_tissue | 1.16370500 |
| 84 | MP0002971_abnormal_brown_adipose | 1.14472719 |
| 85 | MP0005164_abnormal_response_to | 1.13854591 |
| 86 | MP0004272_abnormal_basement_membrane | 1.12721714 |
| 87 | MP0009115_abnormal_fat_cell | 1.11828341 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.10480787 |
| 89 | MP0001790_abnormal_immune_system | 1.10356553 |
| 90 | MP0005387_immune_system_phenotype | 1.10356553 |
| 91 | MP0006054_spinal_hemorrhage | 1.09908896 |
| 92 | MP0005000_abnormal_immune_tolerance | 1.09808509 |
| 93 | MP0001915_intracranial_hemorrhage | 1.09225141 |
| 94 | MP0003075_altered_response_to | 1.08106892 |
| 95 | * MP0005380_embryogenesis_phenotype | 1.07806301 |
| 96 | * MP0001672_abnormal_embryogenesis/_devel | 1.07806301 |
| 97 | MP0001545_abnormal_hematopoietic_system | 1.07692231 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 1.07692231 |
| 99 | MP0003436_decreased_susceptibility_to | 1.07670370 |
| 100 | MP0004130_abnormal_muscle_cell | 1.06133072 |
| 101 | MP0001835_abnormal_antigen_presentation | 1.04761255 |
| 102 | MP0003123_paternal_imprinting | 1.04246508 |
| 103 | MP0003690_abnormal_glial_cell | 1.03350699 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 1.03062454 |
| 105 | MP0001727_abnormal_embryo_implantation | 1.02269834 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 1.01301981 |
| 107 | MP0000350_abnormal_cell_proliferation | 1.00891233 |
| 108 | MP0008058_abnormal_DNA_repair | 1.00883125 |
| 109 | MP0000372_irregular_coat_pigmentation | 0.98304132 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.97630714 |
| 111 | MP0000266_abnormal_heart_morphology | 0.97285778 |
| 112 | MP0001730_embryonic_growth_arrest | 0.97266497 |
| 113 | MP0010155_abnormal_intestine_physiology | 0.96895244 |
| 114 | MP0003279_aneurysm | 0.96823814 |
| 115 | MP0004233_abnormal_muscle_weight | 0.96577953 |
| 116 | MP0003448_altered_tumor_morphology | 0.95509985 |
| 117 | MP0003186_abnormal_redox_activity | 0.94894562 |
| 118 | MP0002452_abnormal_antigen_presenting | 0.94665646 |
| 119 | MP0002086_abnormal_extraembryonic_tissu | 0.94188394 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.93513822 |
| 121 | MP0009785_altered_susceptibility_to | 0.93356040 |
| 122 | MP0008004_abnormal_stomach_pH | 0.93304406 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.92121204 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.90807566 |
| 125 | MP0009333_abnormal_splenocyte_physiolog | 0.89724615 |
| 126 | MP0002396_abnormal_hematopoietic_system | 0.89438880 |
| 127 | MP0003806_abnormal_nucleotide_metabolis | 0.87158375 |
| 128 | MP0002933_joint_inflammation | 0.87036655 |
| 129 | MP0000858_altered_metastatic_potential | 0.86653344 |
| 130 | MP0001853_heart_inflammation | 0.86482084 |
| 131 | MP0000678_abnormal_parathyroid_gland | 0.86115600 |
| 132 | MP0000516_abnormal_urinary_system | 0.85705368 |
| 133 | MP0005367_renal/urinary_system_phenotyp | 0.85705368 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.84458839 |
| 135 | MP0004145_abnormal_muscle_electrophysio | 0.84013223 |
| 136 | MP0002925_abnormal_cardiovascular_devel | 0.83417625 |
| 137 | MP0009278_abnormal_bone_marrow | 0.83058609 |
| 138 | MP0000371_diluted_coat_color | 0.83056338 |
| 139 | MP0002098_abnormal_vibrissa_morphology | 0.81870404 |
| 140 | MP0009931_abnormal_skin_appearance | 0.80705860 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.80490176 |
| 142 | MP0001697_abnormal_embryo_size | 0.79481144 |
| 143 | MP0000609_abnormal_liver_physiology | 0.77995419 |
| 144 | MP0002723_abnormal_immune_serum | 0.77422012 |
| 145 | MP0000747_muscle_weakness | 0.76884980 |
| 146 | MP0003786_premature_aging | 0.76439614 |
| 147 | MP0008469_abnormal_protein_level | 0.74572111 |
| 148 | MP0001851_eye_inflammation | 0.71948476 |
| 149 | MP0005167_abnormal_blood-brain_barrier | 0.70150098 |
| 150 | MP0002128_abnormal_blood_circulation | 0.69895715 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.69365641 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.69356866 |
| 153 | MP0005377_hearing/vestibular/ear_phenot | 0.69355949 |
| 154 | MP0003878_abnormal_ear_physiology | 0.69355949 |
| 155 | MP0005647_abnormal_sex_gland | 0.68958261 |
| 156 | MP0001849_ear_inflammation | 0.68601612 |
| 157 | MP0005503_abnormal_tendon_morphology | 0.68106966 |
| 158 | MP0005166_decreased_susceptibility_to | 0.68023052 |
| 159 | MP0000685_abnormal_immune_system | 0.67723098 |
| 160 | MP0002060_abnormal_skin_morphology | 0.67454012 |
| 161 | MP0002405_respiratory_system_inflammati | 0.67418499 |
| 162 | MP0002419_abnormal_innate_immunity | 0.67140622 |
| 163 | MP0000003_abnormal_adipose_tissue | 0.67052464 |
| 164 | MP0008932_abnormal_embryonic_tissue | 0.66607194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.01635257 |
| 2 | Ventricular tachycardia (HP:0004756) | 4.38053307 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.21577779 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.21577779 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.21577779 |
| 6 | Abnormality of nail color (HP:0100643) | 4.20839771 |
| 7 | Sudden death (HP:0001699) | 3.96496323 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 3.95067467 |
| 9 | Increased connective tissue (HP:0009025) | 3.93138336 |
| 10 | Lipoatrophy (HP:0100578) | 3.78766607 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.75709174 |
| 12 | Myoglobinuria (HP:0002913) | 3.63884274 |
| 13 | Subaortic stenosis (HP:0001682) | 3.63210737 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.63210737 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.57294035 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 3.56894471 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.55865036 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.52475917 |
| 19 | Muscle fiber splitting (HP:0003555) | 3.51914919 |
| 20 | Atrial fibrillation (HP:0005110) | 3.44276003 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.29134219 |
| 22 | Abnormal gallbladder physiology (HP:0012438) | 3.27447415 |
| 23 | Cholecystitis (HP:0001082) | 3.27447415 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 3.17161648 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.10018258 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.07205980 |
| 27 | Supraventricular tachycardia (HP:0004755) | 3.07006015 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.03629054 |
| 29 | EMG: myopathic abnormalities (HP:0003458) | 3.02517820 |
| 30 | Axonal loss (HP:0003447) | 2.87946340 |
| 31 | Myocardial infarction (HP:0001658) | 2.87261661 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.87225552 |
| 33 | Muscle fiber inclusion bodies (HP:0100299) | 2.86582817 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.84850446 |
| 35 | Dilated cardiomyopathy (HP:0001644) | 2.82598342 |
| 36 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.82334319 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.81051141 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.80234577 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.78553808 |
| 40 | Thick nail (HP:0001805) | 2.78300709 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.77199631 |
| 42 | Hypoplastic ischia (HP:0003175) | 2.70073533 |
| 43 | Flat acetabular roof (HP:0003180) | 2.67936945 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67570055 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.64617022 |
| 46 | Vitreoretinal degeneration (HP:0000655) | 2.60797622 |
| 47 | Metaphyseal cupping (HP:0003021) | 2.59086034 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.58056030 |
| 49 | Nuclear cataract (HP:0100018) | 2.50650553 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.50112797 |
| 51 | Loss of speech (HP:0002371) | 2.49819451 |
| 52 | Increased IgE level (HP:0003212) | 2.48073930 |
| 53 | Nemaline bodies (HP:0003798) | 2.46175096 |
| 54 | Patent foramen ovale (HP:0001655) | 2.45238944 |
| 55 | Disinhibition (HP:0000734) | 2.44517968 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.40429171 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.33842642 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.27909484 |
| 59 | Abnormality of the ischium (HP:0003174) | 2.23386966 |
| 60 | Premature rupture of membranes (HP:0001788) | 2.19367226 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.17528326 |
| 62 | Palpitations (HP:0001962) | 2.16011893 |
| 63 | Neck muscle weakness (HP:0000467) | 2.14456954 |
| 64 | Palmoplantar hyperkeratosis (HP:0000972) | 2.14331991 |
| 65 | Tetraparesis (HP:0002273) | 2.13918807 |
| 66 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.13740405 |
| 67 | Asymmetry of the thorax (HP:0001555) | 2.13643987 |
| 68 | Pulmonary artery stenosis (HP:0004415) | 2.12063348 |
| 69 | Preauricular pit (HP:0004467) | 2.09262082 |
| 70 | Periauricular skin pits (HP:0100277) | 2.09262082 |
| 71 | Areflexia of lower limbs (HP:0002522) | 2.09216526 |
| 72 | Amyloidosis (HP:0011034) | 2.09164833 |
| 73 | Glomerulonephritis (HP:0000099) | 2.08982893 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.08537968 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08537968 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.07054215 |
| 77 | Upper motor neuron abnormality (HP:0002127) | 2.06319216 |
| 78 | Esophageal varix (HP:0002040) | 2.05605816 |
| 79 | Spinal cord lesions (HP:0100561) | 2.04660458 |
| 80 | Syringomyelia (HP:0003396) | 2.04660458 |
| 81 | Irregular epiphyses (HP:0010582) | 2.03659639 |
| 82 | Rectal fistula (HP:0100590) | 2.03309223 |
| 83 | Rectovaginal fistula (HP:0000143) | 2.03309223 |
| 84 | Gangrene (HP:0100758) | 2.03145545 |
| 85 | Palmar hyperkeratosis (HP:0010765) | 2.02445714 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 1.99802467 |
| 87 | Carpal bone hypoplasia (HP:0001498) | 1.99576542 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98633993 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98633993 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98633993 |
| 91 | Thin bony cortex (HP:0002753) | 1.98617529 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97548569 |
| 93 | Multiple enchondromatosis (HP:0005701) | 1.97264339 |
| 94 | Plantar hyperkeratosis (HP:0007556) | 1.97211722 |
| 95 | Intestinal fistula (HP:0100819) | 1.95729117 |
| 96 | Small epiphyses (HP:0010585) | 1.94528362 |
| 97 | Chromsome breakage (HP:0040012) | 1.94348073 |
| 98 | Nausea (HP:0002018) | 1.92999763 |
| 99 | Abnormality of glycolysis (HP:0004366) | 1.92723012 |
| 100 | Apathy (HP:0000741) | 1.90562017 |
| 101 | Urethral obstruction (HP:0000796) | 1.89613351 |
| 102 | Alopecia of scalp (HP:0002293) | 1.88980889 |
| 103 | Ventricular arrhythmia (HP:0004308) | 1.88318544 |
| 104 | Difficulty climbing stairs (HP:0003551) | 1.87702007 |
| 105 | Neonatal short-limb short stature (HP:0008921) | 1.87404963 |
| 106 | Subacute progressive viral hepatitis (HP:0006572) | 1.86383863 |
| 107 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.86028656 |
| 108 | Bone pain (HP:0002653) | 1.85587851 |
| 109 | Hip contracture (HP:0003273) | 1.85125648 |
| 110 | Cupped ribs (HP:0000887) | 1.83221001 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 1.83181637 |
| 112 | Hyperacusis (HP:0010780) | 1.82192210 |
| 113 | Ulnar deviation of the wrist (HP:0003049) | 1.81936230 |
| 114 | Skin nodule (HP:0200036) | 1.81498953 |
| 115 | Diminished motivation (HP:0000745) | 1.81060772 |
| 116 | Palmoplantar keratoderma (HP:0000982) | 1.81012147 |
| 117 | Pigmentary retinal degeneration (HP:0001146) | 1.80703150 |
| 118 | Hypercholesterolemia (HP:0003124) | 1.79896095 |
| 119 | Difficulty running (HP:0009046) | 1.79363458 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 1.77707158 |
| 121 | Natal tooth (HP:0000695) | 1.77572051 |
| 122 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.77006010 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.76347058 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.76141508 |
| 125 | Dyschromatopsia (HP:0007641) | 1.75793858 |
| 126 | Peripheral demyelination (HP:0011096) | 1.75294485 |
| 127 | Atrophic scars (HP:0001075) | 1.74718776 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.70837711 |
| 129 | Scapular winging (HP:0003691) | 1.70770940 |
| 130 | Abnormality of the lumbar spine (HP:0100712) | 1.70169632 |
| 131 | Onycholysis (HP:0001806) | 1.70012955 |
| 132 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.69862233 |
| 133 | Selective tooth agenesis (HP:0001592) | 1.69297386 |
| 134 | Esophageal neoplasm (HP:0100751) | 1.68501914 |
| 135 | Neoplasm of head and neck (HP:0012288) | 1.68501914 |
| 136 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67997520 |
| 137 | Transposition of the great arteries (HP:0001669) | 1.67887175 |
| 138 | Abnormal connection of the cardiac segments (HP:0011545) | 1.67887175 |
| 139 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.67887175 |
| 140 | Advanced eruption of teeth (HP:0006288) | 1.67282787 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.66605748 |
| 142 | Metaphyseal irregularity (HP:0003025) | 1.66348778 |
| 143 | Depressed nasal tip (HP:0000437) | 1.66070933 |
| 144 | Arterial tortuosity (HP:0005116) | 1.65985520 |
| 145 | Long clavicles (HP:0000890) | 1.65639523 |
| 146 | Duplicated collecting system (HP:0000081) | 1.65331462 |
| 147 | Cerebral aneurysm (HP:0004944) | 1.65056143 |
| 148 | Prostate neoplasm (HP:0100787) | 1.64285136 |
| 149 | Congenital stationary night blindness (HP:0007642) | 1.64096507 |
| 150 | Skin pits (HP:0100276) | 1.63989242 |
| 151 | Spinal rigidity (HP:0003306) | 1.63612899 |
| 152 | Generalized muscle weakness (HP:0003324) | 1.63136402 |
| 153 | Vaginal fistula (HP:0004320) | 1.63118796 |
| 154 | Ankyloglossia (HP:0010296) | 1.62136746 |
| 155 | Ectropion (HP:0000656) | 1.61689175 |
| 156 | Recurrent abscess formation (HP:0002722) | 1.61663755 |
| 157 | Mediastinal lymphadenopathy (HP:0100721) | 1.61614844 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.60723885 |
| 159 | Syncope (HP:0001279) | 1.60431806 |
| 160 | Orchitis (HP:0100796) | 1.60430235 |
| 161 | Chorioretinal atrophy (HP:0000533) | 1.60086355 |
| 162 | Erythema (HP:0010783) | 1.60084760 |
| 163 | Abnormality of the salivary glands (HP:0010286) | 1.58429596 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.58354416 |
| 165 | Coarse hair (HP:0002208) | 1.58353858 |
| 166 | Retrobulbar optic neuritis (HP:0100654) | 1.58320107 |
| 167 | Optic neuritis (HP:0100653) | 1.58320107 |
| 168 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.57897694 |
| 169 | Hammertoe (HP:0001765) | 1.57327403 |
| 170 | Persistence of primary teeth (HP:0006335) | 1.57046850 |
| 171 | Termporal pattern (HP:0011008) | 1.56960737 |
| 172 | Insidious onset (HP:0003587) | 1.56960737 |
| 173 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.56626706 |
| 174 | Abnormality of the acetabulum (HP:0003170) | 1.56492806 |
| 175 | Distal upper limb amyotrophy (HP:0007149) | 1.56040858 |
| 176 | Upper limb amyotrophy (HP:0009129) | 1.56040858 |
| 177 | Abnormal atrioventricular conduction (HP:0005150) | 1.55953296 |
| 178 | Ureteral duplication (HP:0000073) | 1.55886017 |
| 179 | Short humerus (HP:0005792) | 1.55647618 |
| 180 | Epiphyseal dysplasia (HP:0002656) | 1.55025997 |
| 181 | Vertebral arch anomaly (HP:0008438) | 1.54886764 |
| 182 | Femoral bowing (HP:0002980) | 1.54649911 |
| 183 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.53747452 |
| 184 | Agnosia (HP:0010524) | 1.53657997 |
| 185 | Rimmed vacuoles (HP:0003805) | 1.52055331 |
| 186 | Abnormality of the renal collecting system (HP:0004742) | 1.51427140 |
| 187 | Osteolytic defects of the hand bones (HP:0009699) | 1.50585149 |
| 188 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.50585149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.63112202 |
| 2 | ZAK | 3.23663898 |
| 3 | TTN | 3.17641962 |
| 4 | STK38L | 2.63787712 |
| 5 | ICK | 2.63566473 |
| 6 | STK24 | 2.52970819 |
| 7 | PKN2 | 2.51298088 |
| 8 | PRPF4B | 2.44980111 |
| 9 | MAP3K3 | 2.36827439 |
| 10 | FGFR4 | 2.33081645 |
| 11 | DDR2 | 2.29869054 |
| 12 | CDK12 | 2.19761423 |
| 13 | MAP3K13 | 2.16982690 |
| 14 | LATS2 | 2.14616205 |
| 15 | MOS | 2.13662552 |
| 16 | MYLK | 2.12241226 |
| 17 | EPHA2 | 1.98367585 |
| 18 | PDGFRA | 1.97516532 |
| 19 | ERN1 | 1.95619706 |
| 20 | MAP3K9 | 1.91711400 |
| 21 | MAP3K14 | 1.87187969 |
| 22 | PDK2 | 1.85534015 |
| 23 | PIK3CA | 1.83865181 |
| 24 | BLK | 1.70935108 |
| 25 | MST1R | 1.68774945 |
| 26 | MAP2K3 | 1.66815520 |
| 27 | PBK | 1.63006843 |
| 28 | FLT3 | 1.60104369 |
| 29 | TRPM7 | 1.59688213 |
| 30 | NEK1 | 1.56882295 |
| 31 | FGR | 1.55217407 |
| 32 | RPS6KB2 | 1.54582863 |
| 33 | MATK | 1.51841213 |
| 34 | KSR2 | 1.49456359 |
| 35 | SMG1 | 1.48854925 |
| 36 | RIPK4 | 1.48247579 |
| 37 | STK4 | 1.47101205 |
| 38 | SIK1 | 1.33254071 |
| 39 | TTK | 1.32316762 |
| 40 | TYRO3 | 1.30600440 |
| 41 | WEE1 | 1.29886198 |
| 42 | STK3 | 1.26760008 |
| 43 | NEK9 | 1.24968177 |
| 44 | BRSK2 | 1.24168402 |
| 45 | ARAF | 1.20538243 |
| 46 | PIM1 | 1.20213073 |
| 47 | MARK3 | 1.19979112 |
| 48 | GRK7 | 1.19129471 |
| 49 | BRD4 | 1.18093339 |
| 50 | STK10 | 1.12254497 |
| 51 | PDK3 | 1.12238449 |
| 52 | PDK4 | 1.12238449 |
| 53 | YES1 | 1.07061417 |
| 54 | RPS6KA4 | 1.05414586 |
| 55 | PINK1 | 1.05215180 |
| 56 | EPHB1 | 1.05196520 |
| 57 | MET | 1.03819044 |
| 58 | TSSK6 | 1.03770095 |
| 59 | RIPK1 | 1.02002270 |
| 60 | IKBKB | 1.01605236 |
| 61 | CSK | 1.01576045 |
| 62 | IRAK4 | 1.00963393 |
| 63 | IRAK3 | 1.00773909 |
| 64 | CDC42BPA | 1.00412833 |
| 65 | DMPK | 0.99936933 |
| 66 | EIF2AK1 | 0.99829279 |
| 67 | TGFBR1 | 0.99798378 |
| 68 | TGFBR2 | 0.98738417 |
| 69 | FGFR3 | 0.97805040 |
| 70 | MAP3K6 | 0.95511741 |
| 71 | JAK3 | 0.95416297 |
| 72 | NME2 | 0.95220322 |
| 73 | LATS1 | 0.95187264 |
| 74 | MAP3K1 | 0.94423411 |
| 75 | PLK4 | 0.91843712 |
| 76 | CHUK | 0.91745273 |
| 77 | SRPK1 | 0.89761418 |
| 78 | CAMK1D | 0.87810387 |
| 79 | SIK2 | 0.86797591 |
| 80 | SIK3 | 0.86612702 |
| 81 | EPHA3 | 0.85200726 |
| 82 | CDK4 | 0.84675456 |
| 83 | PAK4 | 0.84589759 |
| 84 | EIF2AK2 | 0.83134374 |
| 85 | RET | 0.83046094 |
| 86 | MTOR | 0.82240397 |
| 87 | MAP3K10 | 0.81963429 |
| 88 | PIM2 | 0.81940901 |
| 89 | PLK3 | 0.79843840 |
| 90 | AKT3 | 0.79343921 |
| 91 | PDGFRB | 0.78375276 |
| 92 | BMX | 0.78277995 |
| 93 | PTK6 | 0.77570507 |
| 94 | AURKB | 0.77407860 |
| 95 | MAP3K8 | 0.76388289 |
| 96 | CDK7 | 0.76353891 |
| 97 | MKNK1 | 0.75344505 |
| 98 | FGFR1 | 0.75047969 |
| 99 | JAK2 | 0.74753772 |
| 100 | EEF2K | 0.73963988 |
| 101 | KSR1 | 0.73236288 |
| 102 | NTRK1 | 0.71315376 |
| 103 | TAOK1 | 0.70588895 |
| 104 | ATR | 0.70192988 |
| 105 | CDC7 | 0.69522836 |
| 106 | PLK1 | 0.69384259 |
| 107 | CLK1 | 0.68631841 |
| 108 | ZAP70 | 0.67500160 |
| 109 | MELK | 0.66460615 |
| 110 | ILK | 0.64246263 |
| 111 | MKNK2 | 0.64190488 |
| 112 | TXK | 0.64084519 |
| 113 | DYRK1B | 0.62787978 |
| 114 | PDPK1 | 0.62692762 |
| 115 | PHKG2 | 0.62342628 |
| 116 | PHKG1 | 0.62342628 |
| 117 | ERBB3 | 0.62283214 |
| 118 | WNK1 | 0.60036307 |
| 119 | LMTK2 | 0.59949824 |
| 120 | TESK1 | 0.57176265 |
| 121 | TAOK2 | 0.56277668 |
| 122 | RPS6KC1 | 0.56025241 |
| 123 | RPS6KL1 | 0.56025241 |
| 124 | CAMK1G | 0.55757332 |
| 125 | ALK | 0.55459331 |
| 126 | PRKAA2 | 0.54391406 |
| 127 | PTK2 | 0.54292676 |
| 128 | MAPKAPK3 | 0.54052139 |
| 129 | MAP3K5 | 0.53768743 |
| 130 | TBK1 | 0.53526415 |
| 131 | TNIK | 0.53276253 |
| 132 | CDK6 | 0.52723689 |
| 133 | PASK | 0.52079964 |
| 134 | EIF2AK3 | 0.51563137 |
| 135 | RPS6KA2 | 0.51026484 |
| 136 | RPS6KA6 | 0.50186767 |
| 137 | CSF1R | 0.49059182 |
| 138 | PRKG2 | 0.48771181 |
| 139 | IRAK1 | 0.48304317 |
| 140 | EPHB2 | 0.46352933 |
| 141 | AKT2 | 0.46194583 |
| 142 | TYK2 | 0.45837783 |
| 143 | RPS6KA1 | 0.45562916 |
| 144 | MST4 | 0.45151900 |
| 145 | TRIB3 | 0.44838319 |
| 146 | BCR | 0.44238949 |
| 147 | MAPKAPK2 | 0.43665980 |
| 148 | CDK9 | 0.42767364 |
| 149 | PDK1 | 0.41200563 |
| 150 | NUAK1 | 0.39963425 |
| 151 | ATM | 0.39727427 |
| 152 | IKBKE | 0.39517209 |
| 153 | JAK1 | 0.38487656 |
| 154 | PAK2 | 0.38316010 |
| 155 | NEK6 | 0.38284390 |
| 156 | CHEK1 | 0.37838201 |
| 157 | NME1 | 0.37713671 |
| 158 | MUSK | 0.37676102 |
| 159 | MAP3K11 | 0.36933934 |
| 160 | NEK2 | 0.35561559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.01313599 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.94595319 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.40955622 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.40794478 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.40715494 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.13418941 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.10015029 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.07011633 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.00240486 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.86704097 |
| 11 | Bladder cancer_Homo sapiens_hsa05219 | 1.85580590 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.80388908 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77939084 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77033790 |
| 15 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72796935 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71395561 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69344671 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.66117930 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.63140026 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.59601415 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58501076 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58313626 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56546805 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55850820 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.48479977 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47894075 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45940532 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43225744 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39864488 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.39654078 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.38087657 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.37838761 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37640630 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.34051599 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.33583774 |
| 36 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.32784030 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.32269556 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.24491757 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24251021 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22968996 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21922550 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20214711 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.19592775 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17409785 |
| 45 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.16793731 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.14949426 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14665003 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 1.14384915 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12961333 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11925999 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.11823693 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09529694 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09214044 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08434129 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.08025864 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.07761012 |
| 57 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.06093356 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.05853631 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04619978 |
| 60 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04201491 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02987921 |
| 62 | Malaria_Homo sapiens_hsa05144 | 1.02142804 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.01885193 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01863018 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01552979 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01397353 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00370837 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98941079 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.98620949 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97001226 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96023277 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95890172 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.95797512 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94622126 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94256660 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94248162 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93594646 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.93539009 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92702545 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.92439258 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92322769 |
| 82 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91724777 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.89959132 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89674940 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88957232 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87309515 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86967192 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86767426 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85180574 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84252740 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.83584532 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83527439 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83266264 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.81820244 |
| 95 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81794126 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80827626 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80172351 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79008095 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78622696 |
| 100 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78573759 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74687524 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.73967390 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73853616 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72868761 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72816891 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.72766241 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72432222 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71179891 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70945120 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70314352 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.69844341 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69616373 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68336376 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67618743 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67219173 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.66232148 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65417923 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.64846905 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64655066 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64594314 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.64287753 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63571558 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63023266 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62266576 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61693172 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61401663 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59516665 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59217505 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58800225 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57833783 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57800433 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55346278 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55289996 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54835996 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.54469547 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53336555 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51472355 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51032762 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50437382 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49387507 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.47209567 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47106797 |
| 143 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46799149 |
| 144 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46228685 |
| 145 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44974078 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44865212 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42917484 |
| 148 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42248471 |

